# Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques

> **NCT05289895** · — · UNKNOWN · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 220 (estimated)

## Conditions studied

- Proteomics
- Pancreatic Cancer
- Prognostic Biomarkers

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05289895
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2023-03-01
- **Final completion:** 2024-12-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05289895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05289895, "Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05289895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*